ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ATRA Atara Biotherapeutics Inc

0.661
-0.0307 (-4.44%)
Apr 19 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,626,286
Bid Price 0.6361
Ask Price 0.723
News -
Day High 0.7074

Low
0.1986

52 Week Range

High
3.06

Day Low 0.6401
Company Name Stock Ticker Symbol Market Type
Atara Biotherapeutics Inc ATRA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0307 -4.44% 0.661 18:00:05
Open Price Low Price High Price Close Price Prev Close
0.69 0.6401 0.7074 0.661 0.6917
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
6,215 1,626,286 $ 0.672044 $ 1,092,936 - 0.1986 - 3.06
Last Trade Time Type Quantity Stock Price Currency
17:48:03 1 $ 0.6371 USD

Atara Biotherapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
68.29M 101.92M - 63.57M -230M -2.26 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Atara Biotherapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ATRA Message Board. Create One! See More Posts on ATRA Message Board See More Message Board Posts

Historical ATRA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.71240.74270.64010.69273381,119,369-0.0514-7.22%
1 Month0.70630.83250.61940.71429881,147,920-0.0453-6.41%
3 Months0.601.580.56860.90002092,827,5090.06110.17%
6 Months1.491.580.19860.63617013,936,940-0.829-55.64%
1 Year2.903.060.19861.012,730,038-2.24-77.21%
3 Years13.2020.040.19864.291,748,666-12.54-94.99%
5 Years31.6536.550.19866.901,377,799-30.99-97.91%

Atara Biotherapeutics Description

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and CAR T Programs.

Your Recent History

Delayed Upgrade Clock